Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Kathryn B. Holroyd"'
Publikováno v:
Disease Models & Mechanisms, Vol 6, Iss 3, Pp 819-827 (2013)
SUMMARY Characterizing dopaminergic neuronal development and function in novel genetic animal models might uncover strategies for researchers to develop disease-modifying treatments for neurologic disorders. Id2 is a transcription factor expressed in
Externí odkaz:
https://doaj.org/article/f32978a8759341948ac85b6b79deddfa
Publikováno v:
Multiple Sclerosis Journal. 29:471-474
Background: There is concern that immune checkpoint inhibitors (ICPIs) can provoke relapses in people with multiple sclerosis (pwMS). Objective: Analyze outcomes of pwMS who received ICPI treatment for malignancy. Methods: We electronically identifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6452f86bda2bc38a7f6846652d32f762
https://doi.org/10.1177/13524585221117949
https://doi.org/10.1177/13524585221117949
Autor:
Kathryn B. Holroyd, Sarah E. Conway
Publikováno v:
Seminars in Neurology.
Autoimmune disorders of the central nervous system following COVID-19 infection include multiple sclerosis (MS), neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, autoimmune encephalitis, acute d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72101d8dd4773458e518445fd924b8e7
https://doi.org/10.1055/s-0043-1767713
https://doi.org/10.1055/s-0043-1767713
Autor:
Kathryn B. Holroyd, Aaron L. Berkowitz
Publikováno v:
Seminars in Neurology.
Neurologic symptoms have been reported in over 30% of hospitalized patients with coronavirus disease 2019 (COVID-19), but the pathogenesis of these symptoms remains under investigation. Here, we place the neurologic complications of COVID-19 within t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fd8ffdf2f68ebc3b707623d8783489b
https://doi.org/10.1055/s-0043-1767714
https://doi.org/10.1055/s-0043-1767714
Publikováno v:
Seminars in Neurology. 41:588-605
Neurologic symptoms are commonly seen in patients with cancer and can be among the most challenging to diagnose and manage. It is often difficult to determine if new neurologic symptoms are secondary to direct effects of a malignant lesion, systemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e40db6441867646cb9929162b56a54c
https://doi.org/10.1055/s-0041-1733788
https://doi.org/10.1055/s-0041-1733788
Autor:
Dylan R. Rice, Kathryn B. Holroyd, Danielle Kei Pua, Michael Levy, Farrah J. Mateen, Shamik Bhattacharyya
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104580
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::974e5554d33af0a39d050144b6ac4d21
https://doi.org/10.1016/j.msard.2023.104580
https://doi.org/10.1016/j.msard.2023.104580
Publikováno v:
Curr Opin Ophthalmol
Purpose of review Neuromyelitis optica spectrum disorder is an autoimmune disease that causes optic neuritis and transverse myelitis. Attacks can cause severe neurological damage leading to blindness and paralysis. Understanding of the immunopathogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ccec3acf54b96faa1d102f80128b615
https://doi.org/10.1097/icu.0000000000000703
https://doi.org/10.1097/icu.0000000000000703
Autor:
Aleksandar Videnovic, Farrah J. Mateen, Andre C. Vogel, Kathryn B. Holroyd, Matthew Stauder, Natalie C. Manalo, Gladia C. Hotan, Tamara B. Kaplan, Sara J. Grundy
Publikováno v:
Journal of Neurology. 267:2319-2327
Bright white light therapy (LT) can improve fatigue in several disease states but has not been studied in multiple sclerosis (MS). To determine whether controlled home-based LT is feasible, tolerable, and well-adhered to in MS-associated fatigue. A r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f9efa4adb073deb93d8b9547d097f98
https://doi.org/10.1007/s00415-020-09845-w
https://doi.org/10.1007/s00415-020-09845-w
Autor:
Giovanna S. Manzano, Kathryn B. Holroyd, Tamara Kaplan, Shamik Bhattacharyya, Tanuja Chitnis, Gladia Hotan, Jonathan Zurawski, Kristin M. Galetta, Farrah J. Mateen
Publikováno v:
Multiple sclerosis and related disorders. 63
Stem cell therapies (SCT) have not received formal regulatory approval for the treatment of people with multiple sclerosis (PwMS), but PwMS may seek various options on their own accord. The current literature largely focuses on the efficacy and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70c70a7189eba06f6900d153eac5c7de
https://pubmed.ncbi.nlm.nih.gov/35576727
https://pubmed.ncbi.nlm.nih.gov/35576727
Autor:
David Pilgrim, Anthony A. Amato, Stephen A. Johnson, Kathryn B. Holroyd, Alejandra M. Márquez Loza
Publikováno v:
Neurology. 96:1052-1054
There are reports of Guillain-Barre syndrome (GBS) and cranial neuropathies occurring during or shortly after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.1,2 Some recent infections are known to trigger GBS. A recent epidemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2f4656b972397bfb259eaf757486b14
https://doi.org/10.1212/wnl.0000000000011881
https://doi.org/10.1212/wnl.0000000000011881